The United States (FDA) has authorized the use of an experimental drug against corona virus (COVID-19).

The United States (FDA) has authorized the use of an experimental drug against corona virus (COVID-19).

Gilead, director of the US laboratory, said Sunday that Washington will not block the export of the experimental antiviral drug Remdesivir. According to an extensive clinical study, the drug reduces the recovery time of (Covid-19) in the most severely affected patients by several days.

“I think that with the US government we are at the stage of providing services to both patients in the United States and patients in other countries around the world,” said Daniel O'Day at the US CBS station.

The US Food and Drug Administration (FDA) has issued emergency approval for Remdesivir . This will allow hospitals to use it to treat patients with the most severe course of (Covid-19) without participating in clinical trials.


- We transferred to the US government all the stocks that are in our supply chain. Patients will have access in the United States and around the world when other regulatory decisions are made for these countries, ”said Daniel O'Day.

Remdesivir , an experimental drug originally developed to treat patients with Ebola hemorrhagic fever , is the first therapy that has shown some efficacy in such a large study - in a group of more than a thousand patients.